Efficacy and safety of daclizumab beta in patients with relapsing-remitting MS switching from natalizumab: Rationale and study design of the phase 3b SUSTAIN study

Authors

• Stanley Cohan, Providence Multiple Sclerosis Center, USA.Follow

Document Type

Presentation

Publication Date

2017

Keywords

oregon; providence neuroscience institute

Area of Special Interest

Neurosciences (Brain & Spine)

Specialty/Research Institute

Neurosciences